Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Efpeglenatide

Drug

Open in the dashboard

General payments

$3,406

20 payments

Research payments

$3,912,111

1,325 payments

Through program year 2019, $3,406 in general payments and $3,912,111 in research payments were reported against Efpeglenatide.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $3,406 20
2019 Research $3,912,111 1,325

Breakdown

Who paid General payments · program year 2019
  1. Sanofi US Services Inc. $3,240 8 payments
  2. Sanofi-Aventis U.S. LLC $166 12 payments
Top recipients General payments · program year 2019
  1. Kenneth Mahaffey Cardiovascular Disease · Stanford, CA $1,690 50% · 3 payments
  2. Joseph Jordan Neurocritical Care · Tucson, AZ $1,550 46% · 5 payments
  3. Kathryn Lucas Endocrinology, Diabetes & Metabolism · Morehead City, NC $24 <1% · 2 payments
  4. Jack Wahlen Endocrinology, Diabetes & Metabolism · Ogden, UT $22 <1% · 1 payment
  5. Lawrence Feld Family Medicine · Gilbert, AZ $22 <1% · 1 payment

The top 5 of 11 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Cardiovascular Disease Internal Medicine $1,690 50% · 1 practitioner
  2. Neurocritical Care Psychiatry & Neurology $1,550 46% · 1 practitioner
  3. Endocrinology, Diabetes & Metabolism Internal Medicine $97 3% · 5 practitioners
  4. Family Medicine $36 1% · 2 practitioners
  5. Internal Medicine $32 <1% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019
  1. California $1,690 50% · 1 recipient
  2. Maryland $1,550 46% · 1 recipient
  3. North Carolina $63 2% · 3 recipients
  4. Arizona $48 1% · 3 recipients
  5. Utah $22 <1% · 1 recipient

The top 5 of 7 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

20 general · 1,325 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record